Pneumococcal pneumonia is community-acquired pneumonia caused by Streptococcus pneumoniae, the most common bacterial cause of community-acquired pneumonia, particularly among hospitalized patients. After nasopharyngeal colonization, the encapsulated organism invades the lower respiratory tract and produces a typical lobar pneumonia. As a classic cell-walled (Gram-positive) bacterium, it is treated with beta-lactam antibiotics that target the penicillin-binding-protein transpeptidases — the diametric opposite of cell-wall-deficient atypical pathogens such as Mycoplasma. Acquired penicillin resistance via altered penicillin-binding proteins is widespread, and conjugate vaccines have reduced invasive pneumococcal disease.
Ask a research question about Pneumococcal Pneumonia. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Pneumococcal Pneumonia
creation_date: "2026-06-28T00:00:00Z"
description: >
Pneumococcal pneumonia is community-acquired pneumonia caused by Streptococcus
pneumoniae, the most common bacterial cause of community-acquired pneumonia,
particularly among hospitalized patients. After nasopharyngeal colonization, the
encapsulated organism invades the lower respiratory tract and produces a typical
lobar pneumonia. As a classic cell-walled (Gram-positive) bacterium, it is
treated with beta-lactam antibiotics that target the penicillin-binding-protein
transpeptidases — the diametric opposite of cell-wall-deficient atypical
pathogens such as Mycoplasma. Acquired penicillin resistance via altered
penicillin-binding proteins is widespread, and conjugate vaccines have reduced
invasive pneumococcal disease.
category: Infectious Disease
parents:
- Bacterial Respiratory Infection
synonyms:
- Streptococcus pneumoniae pneumonia
- Pneumococcal community-acquired pneumonia
disease_term:
preferred_term: pneumococcal pneumonia
term:
id: MONDO:0005114
label: pneumococcal infection
pathophysiology:
- name: Pneumococcal Colonization and Lower Airway Invasion
role: trigger
description: >
Streptococcus pneumoniae colonizes the nasopharynx and, in susceptible hosts,
invades the lower respiratory tract. It remains the most common bacterial cause
of community-acquired pneumonia, especially among patients requiring
hospitalization. This colonizing/invading organism is the proximal event from
which the lobar pneumonia and the antibiotic-target biology follow.
cell_types:
- preferred_term: respiratory epithelial cell
term:
id: CL:0002632
label: epithelial cell of lower respiratory tract
biological_processes:
- preferred_term: adhesion of symbiont to host
term:
id: GO:0044406
label: adhesion of symbiont to host
evidence:
- reference: PMID:42203421
reference_title: "Evolving Etiology of Community-Acquired Pneumonia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Although Streptococcus pneumoniae remains the most common bacterial cause of
CAP, particularly among patients requiring hospitalization, its frequency has
declined.
explanation: >-
Establishes S. pneumoniae as the most common bacterial cause of
community-acquired pneumonia. Evidence source is OTHER as this is a review
article.
downstream:
- target: Lobar Pneumonia
description: >-
Lower-airway invasion produces a typical lobar pneumonia.
- target: Penicillin-Binding Protein Transpeptidase (Beta-Lactam Target)
description: >-
The organism's cell-wall cross-linking enzymes are the target of beta-lactam
therapy.
- name: Lobar Pneumonia
role: consequence
description: >
Invasion of the alveolar spaces produces a typical lobar pneumonia with
consolidation, fever, productive cough, and dyspnea; bacteremia and
parapneumonic effusion may complicate severe disease.
biological_processes:
- preferred_term: inflammatory response
term:
id: GO:0006954
label: inflammatory response
modifier: INCREASED
locations:
- preferred_term: lung
term:
id: UBERON:0002048
label: lung
evidence:
- reference: PMID:42203421
reference_title: "Evolving Etiology of Community-Acquired Pneumonia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Although Streptococcus pneumoniae remains the most common bacterial cause of
CAP, particularly among patients requiring hospitalization, its frequency has
declined.
explanation: >-
Supports pneumococcal pneumonia as a leading form of community-acquired
pneumonia, especially in hospitalized patients. Evidence source is OTHER as
this is a review article.
downstream: []
- name: Penicillin-Binding Protein Transpeptidase (Beta-Lactam Target)
role: therapeutic_vulnerability
conforms_to: "bacterial_cell_wall_synthesis_inhibition#Peptidoglycan Cross-Linking by Penicillin-Binding Proteins"
description: >
As a cell-walled Gram-positive bacterium, S. pneumoniae depends on
penicillin-binding-protein (PBP) transpeptidases to cross-link peptidoglycan.
Beta-lactam antibiotics (penicillins, cephalosporins) acylate these PBPs and
abolish transpeptidation, making them the mainstay of therapy — in direct
contrast to cell-wall-deficient atypical pathogens that lack this target.
biological_processes:
- preferred_term: peptidoglycan-based cell wall biogenesis
term:
id: GO:0009273
label: peptidoglycan-based cell wall biogenesis
evidence:
- reference: PMID:22203377
reference_title: "From the regulation of peptidoglycan synthesis to bacterial growth and morphology."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
although glycan chain polymerization occurs in the absence of
transpeptidation (for example, in the presence of penicillin), efficient
transpeptidation requires ongoing GTase reactions
explanation: >-
States that penicillin abolishes transpeptidation (the PBP cross-linking
reaction), confirming this node as the beta-lactam target. Evidence source is
OTHER as this is a review article.
downstream:
- target: Acquired Penicillin Resistance via Altered PBPs
description: >-
Pneumococci escape beta-lactams by remodeling the PBP target.
- name: Acquired Penicillin Resistance via Altered PBPs
role: adaptive_escape
conforms_to: "bacterial_cell_wall_synthesis_inhibition#Acquired Resistance and Drug Inactivation"
description: >
Penicillin resistance in pneumococci arises chiefly through mosaic
penicillin-binding proteins with reduced beta-lactam affinity, and resistance to
macrolides and other alternatives is widespread, complicating empirical therapy.
biological_processes:
- preferred_term: response to antibiotic
term:
id: GO:0046677
label: response to antibiotic
evidence:
- reference: PMID:38667036
reference_title: "A Review of the Impact of Streptococcal Infections and Antimicrobial Resistance on Human Health."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Resistance to major alternatives of penicillins, macrolides, and lincosamides
has become widespread among pneumococci and streptococci, especially in Asia
explanation: >-
Documents widespread resistance among pneumococci to penicillins and major
alternatives. Evidence source is OTHER as this is a review article.
downstream: []
phenotypes:
- category: Respiratory
name: Pneumonia
description: >
Typical lobar community-acquired pneumonia is the defining manifestation.
phenotype_term:
preferred_term: Pneumonia
term:
id: HP:0002090
label: Pneumonia
evidence:
- reference: PMID:42203421
reference_title: "Evolving Etiology of Community-Acquired Pneumonia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Although Streptococcus pneumoniae remains the most common bacterial cause of
CAP, particularly among patients requiring hospitalization, its frequency has
declined.
explanation: >-
Supports pneumococcal pneumonia (community-acquired pneumonia) as the defining
manifestation. Evidence source is OTHER as this is a review article.
- category: Constitutional
name: Fever
description: >
High fever is typical of acute pneumococcal pneumonia.
phenotype_term:
preferred_term: Fever
term:
id: HP:0001945
label: Fever
- category: Respiratory
name: Cough
description: >
Productive cough is a cardinal symptom.
phenotype_term:
preferred_term: Cough
term:
id: HP:0012735
label: Cough
- category: Respiratory
name: Dyspnea
description: >
Shortness of breath reflects alveolar consolidation.
phenotype_term:
preferred_term: Dyspnea
term:
id: HP:0002094
label: Dyspnea
treatments:
- name: Beta-Lactam Antibiotic Therapy
description: >
Penicillins (and cephalosporins such as ceftriaxone) acylate pneumococcal
penicillin-binding-protein transpeptidases, blocking peptidoglycan cross-linking;
they are the mainstay of therapy, with agent choice guided by local penicillin
resistance.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: benzylpenicillin (penicillin G)
term:
id: CHEBI:18208
label: benzylpenicillin
target_mechanisms:
- target: Penicillin-Binding Protein Transpeptidase (Beta-Lactam Target)
treatment_effect: INHIBITS
description: >-
Beta-lactams acylate the PBP transpeptidases and abolish peptidoglycan
cross-linking, killing the organism.
- name: Pneumococcal Vaccination
description: >
Pneumococcal conjugate and polysaccharide vaccines reduce invasive pneumococcal
disease and have contributed to the declining frequency of pneumococcal CAP.
therapeutic_modality: VACCINE
treatment_term:
preferred_term: vaccination
term:
id: NCIT:C15346
label: Vaccination
evidence:
- reference: PMID:42203421
reference_title: "Evolving Etiology of Community-Acquired Pneumonia."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Several factors likely contribute to the evolving etiology of CAP, including
vaccination programs, pandemics, and changes in host immunity.
explanation: >-
Supports vaccination programs as a driver of the declining frequency of
pneumococcal CAP. Evidence source is OTHER as this is a review article.
notes: >
Created as part of the Respiratory Infections project. The deliberate
cell-walled (typical-pneumonia) counterpart to Mycoplasma_Pneumoniae_Pneumonia:
conforms to the bacterial_cell_wall_synthesis_inhibition module's PBP
cross-linking (beta-lactam target) and acquired-resistance nodes. disease_term
uses MONDO:0005114 (pneumococcal infection) with a more specific preferred_term
because MONDO lacks a dedicated "pneumococcal pneumonia" term. The
infectious_agent (NCBITaxon) block was omitted at creation and S. pneumoniae is
described in the text.
datasets:
- accession: geo:GSE292448
title: RNA profiles in extracellular vesicles from severe sepsis patients reveal pathogen-specific immune signatures in meningococcal versus pneumococcal infections
description: This study is the first to investigate and compare RNA profiles in plasma extracellular vesicles (EVs) isolated from patients with severe sepsis caused by Neisseria meningitidis and patients with systemic infections due to Streptococcus pneumoniae. In some cases, invasive pneumococcal disease can resemble meningococcal infections at the time of hospital admission. Blood samples from a 1980s epidemic in Norway were used to isolate EVs and characterize their RNA content by microarray technology. The results revealed both shared and distinct RNA characteristics between the two patient groups, with 1,798 shared transcripts.
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
data_type: MICROARRAY
sample_count: 21
publication: PMID:42112460
notes: Identified by GEO DataSets index search for Pneumococcal Pneumonia (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
- accession: geo:GSE246398
title: BIOLOGICAL EFFECTS OF CORTICOSTEROIDS ON PNEUMOCOCCAL PNEUMONIA IN MICE AND HUMANS
description: 'Rationale: Streptococcus pneumoniae is the most common bacterial cause of community acquired pneumonia. Some clinical trials have demonstrated a beneficial effect of corticosteroid therapy in community acquired pneumonia, but the mechanisms of this benefit remain unclear. Objectives: To investigate the biologic effects of corticosteroids in pneumococcal pneumonia in mice and in patients Methods: We studied lower respiratory tract transcriptomes from an observational cohort of mechanically ventilated patients and from a pneumonia model in mice. We also carried out comprehensive physiologic, biochemical, and histological analyses in mice to identify mechanisms of lung injury in S.'
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
data_type: BULK_RNA_SEQ
sample_count: 15
publication: PMID:38807178
notes: Identified by GEO DataSets index search for Pneumococcal Pneumonia (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.
- accession: geo:GSE273805
title: TNF Superfamily Member 14 Drives Post-Influenza Depletion of Alveolar Macrophages Enabling Secondary Pneumococcal Pneumonia
description: Secondary bacterial infection, often caused by Streptococcus pneumoniae (Spn), is one of the most frequent and severe complications of influenza A virus (IAV)-induced pneumonia. Phenotyping of the pulmonary innate immune landscape after IAV infection revealed a significant depletion of the tissue-resident alveolar macrophage (TR-AM) population at day 7, which was associated with increased susceptibility to Spn outgrowth. To elucidate the molecular mechanisms underlying TR-AM depletion, and to define putative targets for treatment, we combined single-cell transcriptomics and cell-specific PCR profiling in an unbiased manner, using in vivo models of IAV infection and IAV/Spn co-infection.
organism:
preferred_term: mouse
term:
id: NCBITaxon:10090
label: Mus musculus
data_type: SINGLE_CELL_RNA_SEQ
sample_count: 7
publication: PMID:41252214
notes: Identified by GEO DataSets index search for Pneumococcal Pneumonia (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-08-01. Title, sample count, and organism are GEO's own values.